Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia

Journal of Virological Methods

Volumn 184, Issue 1-2, 2012, Pages 84-92

  Patel, Divya A ^a   Rozek, Laura S ^b   Colacino, Justin A ^b   Van Zomeren Dohm, Adrienne ^b   Ruffin, Mack T ^c   Unger, Elizabeth R ^d   Dolinoy, Dana C ^b   Swan, David C ^d   Onyekwuluje, Juanita ^d   DeGraffinreid, Cecilia R ^e   Paskett, Electra D ^f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Cervical cancer; HPV; Human papillomavirus; Methylation; Screening

Indexed keywords

BISULFITE; TUMOR MARKER;

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CPG ISLAND; CYTOLOGY; DCC GENE; ENHANCER REGION; ESR1 GENE; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LINE1 GENE; MAJOR CLINICAL STUDY; METHYLATION; P16 GENE; PRIORITY JOURNAL; PROMOTER REGION; QUESTIONNAIRE; UNITED STATES; UTERINE CERVIX CANCER; VIRUS GENE; VIRUS GENOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOLOGICAL TECHNIQUES; DNA METHYLATION; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; OHIO; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84863845994     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.05.022     Document Type: Article

References (50)

1. Ahuja N., Issa J.P. Aging, methylation and cancer. Histology and Histopathology 2000, 15:835-842.
2. Apostolidou S., Hadwin R., Burnell M., Jones A., Baff D., Pyndiah N., Mould T., Jacobs I.J., Beddows S., Kocjan G., Widschwendter M. DNA methylation analysis in liquid-based cytology for cervical cancer screening. International Journal of Cancer 2009, 125:2995-3002.
3. Archer K.J., Mas V.R., Maluf D.G., Fisher R.A. High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Molecular Genetics and Genomics 2010, 283:341-349.
4. Badal V., Chuang L.S., Tan E.H., Badal S., Villa L.L., Wheeler C.M., Li B.F., Bernard H.U. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. Journal of Virology 2003, 77:6227-6234.
5. Benoit A.G., Krepart G.V., Lotocki R.J. Results of prior cytologic screening in patients with a diagnosis of stage I carcinoma of the cervix. American Journal of Obstetrics and Gynecology 1984, 148:690-694.
6. Burnett T.S., Sleeman J.P. Uneven distribution of methylation sites within the human papillomavirus la genome: possible relevance to viral gene expression. Nucleic Acids Research 1984, 12:8847-8860.
7. Carvalho A.L., Chuang A., Jiang W.W., Lee J., Begum S., Poeta L., Zhao M., Jeronimo C., Henrique R., Nayak C.S., Park H.L., Brait M.R., Liu C., Zhou S., Koch W., Fazio V.M., Ratovitski E., Trink B., Westra W., Sidransky D., Moon C.S., Califano J.A. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Research 2006, 66:9401-9407.
8. Centers for Disease Control and Prevention, 2002. Cancer death rates-Appalachia, 1994-1998. MMWR. Morbidity and mortality weekly report 51, 527-9.
9. de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras B., Tous S., Felix A., Bravo L.E., Shin H.R., Vallejos C.S., de Ruiz P.A., Lima M.A., Guimera N., Clavero O., Alejo M., Llombart-Bosch A., Cheng-Yang C., Tatti S.A., Kasamatsu E., Iljazovic E., Odida M., Prado R., Seoud M., Grce M., Usubutun A., Jain A., Suarez G.A., Lombardi L.E., Banjo A., Menendez C., Domingo E.J., Velasco J., Nessa A., Chichareon S.C., Qiao Y.L., Lerma E., Garland S.M., Sasagawa T., Ferrera A., Hammouda D., Mariani L., Pelayo A., Steiner I., Oliva E., Meijer C.J., Al-Jassar W.F., Cruz E., Wright T.C., Puras A., Llave C.L., Tzardi M., Agorastos T., Garcia-Barriola V., Clavel C., Ordi J., Andujar M., Castellsague X., Sanchez G.I., Nowakowski A.M., Bornstein J., Munoz N., Bosch F.X. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncology 2010, 11:1048-1056.
10. Duenas-Gonzalez A., Lizano M., Candelaria M., Cetina L., Arce C., Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Molecular Cancer 2005, 4:38.
11. Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., Parkin, D.M., 2010. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010.
12. Furtado Y.L., Almeida G., Lattario F., Silva K.S., Maldonado P., Silveira F.A., do Val I.C., Fonseca R., Carvalho Mda G. The presence of methylation of the p16INK4A gene and human papillomavirus in high-grade cervical squamous intraepithelial lesions. Diagnostic Molecular Pathology 2010, 19:15-19.
13. Goldie S.J., Kohli M., Grima D., Weinstein M.C., Wright T.C., Bosch F.X., Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Journal of National Cancer Institute 2004, 96:604-615.
14. Gustafson K.S., Furth E.E., Heitjan D.F., Fansler Z.B., Clark D.P. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis. Cancer 2004, 102:259-268.
15. Hall H.I., Rogers J.D., Weir H.K., Miller D.S., Uhler R.J. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S. 1976-1996. Cancer 2000, 89:1593-1602.
16. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiology Review 2007, 87:905-931.
17. Henken F.E., Wilting S.M., Overmeer R.M., van Rietschoten J.G., Nygren A.O., Errami A., Schouten J.P., Meijer C.J., Snijders P.J., Steenbergen R.D. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. British Journal of Cancer 2007, 97:1457-1464.
18. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. New England Journal of Medicine 2003, 349:2042-2054.
19. Huang T.H., Lai H.C., Liu H.W., Lin C.J., Wang K.H., Ding D.C., Chu T.Y. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. International Journal of Gynecological Cancer 2010, 20:513-519.
20. Kahn S.L., Ronnett B.M., Gravitt P.E., Gustafson K.S. Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 2008, 114:57-64.
21. Kalantari M., Calleja-Macias I.E., Tewari D., Hagmar B., Lie K., Barrera-Saldana H.A., Wiley D.J., Bernard H.U. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. Journal of Virology 2004, 78:12762-12772.
22. Kazazian H.H., Moran J.V. The impact of L1 retrotransposons on the human genome. Nature Genetics 1998, 19:19-24.
23. Kim J.H., Choi Y.D., Lee J.S., Lee J.H., Nam J.H., Choi C. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecologic Oncology 2010, 116:99-104.
24. Kim J.H., Choi Y.D., Lee J.S., Lee J.H., Nam J.H., Choi C., Kweon S.S., Fackler M.J., Sukumar S. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Virchows Archiv 2010, 457:35-42.
25. Lai H.C., Lin Y.W., Huang R.L., Chung M.T., Wang H.C., Liao Y.P., Su P.H., Liu Y.L., Yu M.H. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 2010, 116:4266-4274.
26. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
27. Lim E.H., Ng S.L., Li J.L., Chang A.R., Ng J., Ilancheran A., Low J., Quek S.C., Tay E.H. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecologic Oncology 2010, 119:225-231.
28. Montz F.J., Monk B.J., Fowler J.M., Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstetrics and Gynecology 1992, 80:385-388.
29. Muller H.M., Widschwendter A., Fiegl H., Goebel G., Wiedemair A., Muller-Holzner E., Marth C., Widschwendter M. A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer. Cancer Letters 2004, 209:231-236.
30. Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., Matchar D.B. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine 2000, 132:810-819.
31. Nehls K., Vinokurova S., Schmidt D., Kommoss F., Reuschenbach M., Kisseljov F., Einenkel J., von Knebel Doeberitz M., Wentzensen N. p16 methylation does not affect protein expression in cervical carcinogenesis. European Journal of Cancer 2008, 44:2496-2505.
32. Nuovo G.J., Plaia T.W., Belinsky S.A., Baylin S.B., Herman J.G. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proceedings of the National Academy of Sciences of United States of America 1999, 96:12754-12759.
33. Onyekwuluje J.M., Steinau M., Swan D.C., Unger E.R. A real-time PCR assay for HPV 52 detection and viral load quantification. Clinical Laboratory 2012, 58:61-66.
34. Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynecological Pathology 1993, 12:186-192.
35. Piyathilake C.J., Macaluso M., Alvarez R.D., Chen M., Badiga S., Edberg J.C., Partridge E.E., Johanning G.L. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 2011, 117:957-963.
36. Rajeevan M.S., Swan D.C., Duncan K., Lee D.R., Limor J.R., Unger E.R. Quantitation of site-specific HPV 16 DNA methylation by Pyrosequencing. Journal of Virological Methods 2006, 138:170-176.
37. Rosl F., Arab A., Klevenz B., Zur Hausen H. The effect of DNA methylation on gene regulation of human papillomaviruses. Journal of General Virology 1993, 74(Pt 5):791-801.
38. Sartor M.A., Dolinoy D.C., Jones T.R., Colacino J.A., Prince M.E., Carey T.E., Rozek L.S. Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 2011, 6:777-787.
39. Schiffman M., Khan M.J., Solomon D., Herrero R., Wacholder S., Hildesheim A., Rodriguez A.C., Bratti M.C., Wheeler C.M., Burk R.D. A study of the impact of adding HPV types to cervical cancer screening and triage tests. Journal of the National Cancer Institute 2005, 97:147-150.
40. Shuangshoti S., Hourpai N., Pumsuk U., Mutirangura A. Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix. Asian Pacific Journal of Cancer Prevention 2007, 8:307-309.
41. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright T., Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. Journal of American Medical Association 2002, 287:2114-2119.
42. Stephen J.K., Chen K.M., Raitanen M., Grenman S., Worsham M.J. DNA hypermethylation profiles in squamous cell carcinoma of the vulva. International Journal of Gynecological Pathology 2009, 28:63-75.
43. Syrjanen K., Kataja V., Yliskoski M., Chang F., Syrjanen S., Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstetrics and Gynecology 1992, 79:675-682.
44. The SAS Institute, 2008. SAS for Windows, Cary, NC.
45. Unger E.R., Steinau M., Rajeevan M.S., Swan D., Lee D.R., Vernon S.D. Molecular markers for early detection of cervical neoplasia. Disease Markers 2004, 20:103-116.
46. Wang S.S., Smiraglia D.J., Wu Y.Z., Ghosh S., Rader J.S., Cho K.R., Bonfiglio T.A., Nayar R., Plass C., Sherman M.E. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Research 2008, 68:2489-2497.
47. Wentzensen N., Sherman M.E., Schiffman M., Wang S.S. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecologic Oncology 2009, 112:293-299.
48. Wisman G.B., Nijhuis E.R., Hoque M.O., Reesink-Peters N., Koning A.J., Volders H.H., Buikema H.J., Boezen H.M., Hollema H., Schuuring E., Sidransky D., van der Zee A.G. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. International Journal of Cancer 2006, 119:1908-1914.
49. Wojdacz T.K., Hansen L.L. Techniques used in studies of age-related DNA methylation changes. Annals of the New York Academy of Sciences 2006, 1067:479-487.
50. Yang A.S., Estecio M.R., Doshi K., Kondo Y., Tajara E.H., Issa J.P. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Research 2004, 32:e38.